| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10963141 | Vaccine | 2016 | 7 Pages |
Abstract
An initial dose of PCV reduced the frequency, but not phenotype distribution, of serotype-specific B cells and also lowered TACI expression in aging HIV+ subjects postvaccination with PPV. These findings suggest that PCV does not enhance cellular responses to revaccination with PPV.
Keywords
CD4Opsonophagocytic killing assayBAFF-ROPAPPVCBCIQRTACITNFRPpsStreptococcus pneumoniaeimmunoglobulin ACIPanalysis of varianceANOVAAntiretroviral therapyAgingB cellscomplete blood countHIV infectioninterquartile rangeARTPneumococcal conjugate vaccinePneumococcal polysaccharide vaccine23-Valent pneumococcal polysaccharide vaccine13-Valent pneumococcal conjugate vaccinehuman immunodeficiency virusHIVPneumococcal polysaccharidePCVAdvisory Committee on Immunization Practices
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Jennifer A. Ohtola, Noor M. Khaskhely, Jessica L. Saul-Mcbeth, Anita S. Iyer, David J. Leggat, Sadik A. Khuder, M.A. Julie Westerink,